SCHEMBL11119840

SCHEMBL11119840

COc1ccccc1OC(=O)Nc1ccc(C2=NNC(=O)CC2C)cc1

nearest known ligand 0.74

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 2/20 0.74
▸ MAPT P10636 1/20 0.74
▸ PDE3B Q13370 14/20 0.66
▸ PDE3A Q14432 14/20 0.66
▸ PDE4A P27815 5/20 0.58
▸ PDE4B Q07343 5/20 0.58
▸ PDE4C Q08493 5/20 0.58
▸ PDE4D Q08499 5/20 0.58
▸ KDM4E B2RXH2 2/20 0.53
▸ ALDH1A1 P00352 2/20 0.53
▸ CYP1A2 P05177 1/20 0.53
▸ CYP3A4 P08684 1/20 0.53
▸ ALOX15 P16050 1/20 0.53
▸ TSHR P16473 1/20 0.53
▸ MAPK1 P28482 1/20 0.53
▸ LMNA P02545 1/20 0.53
▸ BLM P54132 1/20 0.53
▸ NPSR1 Q6W5P4 1/20 0.53
▸ ATM Q13315 1/20 0.51
▸ GPR119 Q8TDV5 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11170712 0.89 PDE3B (0.64) SMN1; SMN2MAPTPDE3BPDE3APDE4A
SCHEMBL11163754 0.87 PDE3B (0.60) SMN1; SMN2MAPTPDE3BPDE3APDE4A
SCHEMBL11176102 0.86 PDE3B (0.72) SMN1; SMN2MAPTPDE3BPDE3APDE4A
SCHEMBL11160996 0.85 PDE3B (0.78) SMN1; SMN2MAPTPDE3BPDE3APDE4A
SCHEMBL11160053 0.84 PDE3B (0.63) SMN1; SMN2MAPTPDE3BPDE3APDE4A
SCHEMBL11173475 0.83 SMN1; SMN2 (0.71) SMN1; SMN2MAPTPDE3BPDE3APDE4A
SCHEMBL11159409 0.82 PDE3B (0.67) SMN1; SMN2MAPTPDE3BPDE3APDE4A
SCHEMBL11161770 0.81 PDE3B (0.76) SMN1; SMN2MAPTPDE3BPDE3APDE4A
SCHEMBL11162804 0.81 PDE3B (0.73) SMN1; SMN2MAPTPDE3BPDE3APDE4A
SCHEMBL25094779 0.80 PDE3B (0.73) SMN1; SMN2MAPTPDE3BPDE3APDE4A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0042513-B1 DIHYDROPYRIDAZINONES, PROCESSES FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THESE COMPOUNDS BASF Aktiengesellschaft (DE) 1984-08-08 — — EP disclosed
US-4415571-A HYPOTENSIVE AGENTS; THROMBOSIS; ANTICOAGULANTS; CARDIOVASCULAR DISORDDERS BASF AKTIENGESELLSCHAFT (DE) 1983-11-15 — — US disclosed
EP-0042513-A1 Dihydropyridazinones, processes for their preparation and pharmaceutical compositions containing these compounds BASF Aktiengesellschaft (DE) 1981-12-30 — — EP disclosed
Send feedback